Literature DB >> 17273799

FDG-PET and CT features of non-small cell lung cancer based on tumor type.

Suzanne L Aquino1, Elkan F Halpern, Landon B Kuester, Alan J Fischman.   

Abstract

We determined if specific tumor types of non-small cell lung cancer can be identified by variance in FDG-PET standard uptake value (SUV) in combination with characteristics on CT. Staging FDG-PET and CT scans of 81 patients (34 men and 47 women, average age 67+/-11 years) with 82 lung cancers were analyzed. Mean tumor SUV was calculated at the location of maximum FDG uptake. Tumor size, margins, and location were analyzed on CT. Statistical analysis compared SUV between tumor subtypes, assessed relationship between tumor subtype and features on CT and determined if combination of CT and SUV patterns predicted tumor type. In total 35 adenocarcinomas (AC); 15 bronchioloalveolar cell carcinomas (BAC), 23 squamous cell carcinomas and 9 large cell carcinomas were evaluated. Significant differences were found between SUV of all AC and squamous cell (p<0.0001); between all AC and large cell (p=0.03); between non-BAC AC and squamous cell types (p=0.0005); BAC and non-BAC AC (p=0.04), BAC and squamous cell (p<0.0001); BAC and large cell (p=0.004). Ground glass was the most significant CT feature in distinguishing tumor types, which was seen in BAC (p<0.0003). In conclusion, SUVs for non-small cell lung cancer were most significantly different between BAC and all other NCLC cell subtypes. The presence of ground glass in a nodule on CT is a significant feature for BAC and should raise the suspicion for this tumor type despite low FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273799

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  14 in total

1.  The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.

Authors:  Bernadette G Dijkman; Olga C J Schuurbiers; Dennis Vriens; Monika Looijen-Salamon; Johan Bussink; Johanna N H Timmer-Bonte; Miranda M Snoeren; Wim J G Oyen; Henricus F M van der Heijden; Lioe-Fee de Geus-Oei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-10       Impact factor: 9.236

2.  Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings.

Authors:  Eiichi Sawada; Atsushi Nambu; Utaroh Motosugi; Tsutomu Araki; Satoshi Kato; Yoko Sato; Akitoshi Saito; Hiroshi Ishihara; Hideto Okuwaki; Katsura Ozawa; Keiichi Nishikawa; Masahisa Miyazawa; Kazuyuki Miyata
Journal:  Jpn J Radiol       Date:  2010-05-29       Impact factor: 2.374

3.  Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.

Authors:  Hu-bing Wu; Lijuan Wang; Quan-shi Wang; Yan-jian Han; Hong-sheng Li; Wen-lan Zhou; Ying Tian
Journal:  Biomed Res Int       Date:  2015-03-24       Impact factor: 3.411

4.  Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.

Authors:  Yuehong Wang; Shanni Ma; Mengjie Dong; Yake Yao; Kanfeng Liu; Jianying Zhou
Journal:  BMC Pulm Med       Date:  2015-03-08       Impact factor: 3.317

5.  Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.

Authors:  Rifeng Jiang; Ximin Dong; Wenzhen Zhu; Qing Duan; Yunjing Xue; Yanxia Shen; Guopeng Zhang
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

6.  Quantitative volumetric metabolic measurement of solitary pulmonary nodules by F-18 fluorodeoxyglucose positron emission tomography-computed tomography.

Authors:  Tarık Şengöz; Dogangün Yüksel; Olga Yaylalı; Haydar Arslan; Ferda Bir
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

7.  Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis.

Authors:  Shahed N Badiyan; Andrew J Bierhals; Jeffrey R Olsen; Kimberly M Creach; Adam A Garsa; Todd Dewees; Jeffrey D Bradley; Clifford G Robinson
Journal:  Radiat Oncol       Date:  2013-01-03       Impact factor: 3.481

8.  Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.

Authors:  John Cuaron; Mark Dunphy; Andreas Rimner
Journal:  Front Oncol       Date:  2013-01-03       Impact factor: 6.244

9.  The maximum standardized FDG uptake on PET-CT in patients with non-small cell lung cancer.

Authors:  Mehmet Akif Ozgül; Gamze Kirkil; Ekrem Cengiz Seyhan; Erdoğan Cetinkaya; Güler Ozgül; Mahmut Yüksel
Journal:  Multidiscip Respir Med       Date:  2013-10-22

10.  Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.

Authors:  Ji Hyung Hong; Hyon Ho Kim; Eun Ji Han; Jae Ho Byun; Hong Seok Jang; Eun Kyoung Choi; Jin Hyoung Kang; Ie Ryung Yoo
Journal:  J Korean Med Sci       Date:  2015-12-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.